Please assess the completion status of the following clinical trial:

Trial Title: Study To Evaluate The Effect Of Single Intravenous Doses Of Tigecycline On QTc Intervals In Healthy Subjects

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy~* Body mass index 17.5 - 30.5 kg~* Total body weight greater than 50 kg~Exclusion Criteria:~* Recent history of diarrhea~* Use of oral antibiotics in the last 2 weeks~* History of risk factors for QT prolongation pregnant females~* Nursing females

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: t

Study Arms:
- high dose tigecycline (Type: EXPERIMENTAL): None
- regular dose tigecycline (Type: EXPERIMENTAL): None
- moxifloxacin (Type: ACTIVE_COMPARATOR): None
- placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).